MedTrace Logo

Letrozole Versus Laparoscopic Ovarian Drilling in Polycystic Ovary Syndrome

NCT03009838 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2022-05-09

No results posted yet for this study

Summary

Polycystic ovary syndrome is the major cause of anovulatory infertility. Clomiphene citrate is the most commonly used oral agent for ovulation induction in this group, but there are some drawbacks with the use of it.

Conditions

Interventions

DRUG

Letrozole

oral tablets 2.5 mg

PROCEDURE

ovarian drilling

laparoscopic electrocauterization

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-02
Primary Completion
2022-12-31
Completion
2023-08-31

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03009838 on ClinicalTrials.gov